Literature DB >> 16409257

Maturation-state dependent response of human periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro.

S Lossdörfer1, S Stier, W Götz, A Jäger.   

Abstract

BACKGROUND AND OBJECTIVES: Parathyroid hormone (parathyroid hormone) has been shown to be capable of exerting anabolic effects on bone when administered intermittently. We hypothesized that parathyroid hormone will modulate the response of periodontal ligament cells in terms of anabolic effects with respect to proliferation, differentiation and the production of key regulatory factors of bone remodeling such as osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) in a maturation-state dependent manner.
METHODS: Periodontal ligament cells were cultured from human bicuspids obtained from six patients. Following characterization, confluent and preconfluent periodontal ligament cells were challenged with parathyroid hormone (1-34) for 0, 1, 3, 6 or 24 h within three incubation cycles of 48 h each. At harvest, the cell number, alkaline phosphatase specific activity and osteocalcin, osteoprotegerin and RANKL production were determined by means of semiquantitative polymerase chain reaction (PCR) and immunoassays. Dermal fibroblasts and MG63 osteoblast-like cells served as a reference.
RESULTS: Intermittent parathyroid hormone treatment of confluent periodontal ligament cells caused a significant increase in proliferation (+32% maximum) whereas alkaline phosphatase activity, osteocalcin and osteoprotegerin decreased at the transcriptional and translational level (-59.7% maximum). In preconfluent periodontal ligament cells, parathyroid hormone induced a decrease in proliferation (-66.3% maximum) but an increase in differentiation and osteoprotegerin production (+49.2% maximum). RANKL was hardly detectable and unaffected by parathyroid hormone treatment. Similar results were obtained in MG63 cells, whereas parathyroid hormone stimulation did not alter any of the parameters examined in dermal fibroblasts.
CONCLUSION: These results indicate that human periodontal ligament cells respond to an intermittent parathyroid hormone exposure with changes in proliferation, differentiation and osteoprotegerin production in a maturation-state dependent manner and therefore might be regulatorily involved in periodontal regeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409257     DOI: 10.1111/j.1600-0765.2005.00838.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  5 in total

1.  Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption.

Authors:  S Lossdörfer; F Yildiz; W Götz; Y Kheralla; A Jäger
Journal:  Clin Oral Investig       Date:  2009-03-12       Impact factor: 3.573

2.  Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.

Authors:  Dominik Kraus; Andreas Jäger; Nuersailike Abuduwali; James Deschner; Stefan Lossdörfer
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

3.  PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells.

Authors:  Stefan Lossdörfer; Werner Götz; Andreas Jäger
Journal:  Clin Oral Investig       Date:  2010-08-10       Impact factor: 3.573

4.  The role of periodontal ligament cells in delayed tooth eruption in patients with cleidocranial dysostosis.

Authors:  Stefan Lossdörfer; Bassel Abou Jamra; Birgit Rath-Deschner; Werner Götz; Rami Abou Jamra; Bert Braumann; Andreas Jäger
Journal:  J Orofac Orthop       Date:  2009-12-04       Impact factor: 1.938

5.  Functional characterization of the parathyroid hormone 1 receptor in human periodontal ligament cells.

Authors:  Nuersailike Abuduwali; Stefan Lossdörfer; Jochen Winter; Dominik Kraus; Stefan Guhlke; Michael Wolf; Andreas Jäger
Journal:  Clin Oral Investig       Date:  2013-04-19       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.